1.
Effect of postmenopausal hormone therapy on body weight and waist and hip girths
by ESPELAND, M. A
The journal of clinical endocrinology and metabolism, 1997, Vol.82 (5), p.1549-1556
2.
Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
by Crouse, John Robert
The American journal of cardiology, 1995-03-01, Vol.75 (7), p.455-459
3.
Pravastatin, lipids, and major coronary events
by Furberg, Curt D
The American journal of cardiology, 1994, Vol.73 (15), p.1133-1134
4.
Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
by Reboussin, B. A
Climacteric : the journal of the International Menopause Society, 1998, Vol.1 (3), p.172-179
5.
Pravastatin, lipids, and atherosclerosis in the carotid arteries (plac-II)
by Byinqton, Robert Patrick
The American journal of cardiology, 1995, Vol.76 (9), p.54C-59C
6.
Racial Differences in HLA Antigen Frequency and Hypertensive Renal Failure
by Freedman, Barry I.
American journal of hypertension, 1991-05, Vol.4 (5-Pt-1), p.393-398
7.
Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?
by Kostis, John B
The American journal of cardiology, 1998, Vol.82 (12), p.1501-1508
8.
Results of the primary outcome measure and clinical events from the asymptomatic carotid artery progression study
by Probstfield, Jeffrey L
The American journal of cardiology, 1995, Vol.76 (9), p.47C-53C
9.
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
by Resnick, Susan M
The journal of clinical endocrinology and metabolism, 2006-05, Vol.91 (5), p.1802-1810
10.
Racial differences in endothelial function in postmenopausal women
by Loehr, Laura R
The American heart journal, 2004, Vol.148 (4), p.606-611
11.
Cardioprotective effects of postmenopausal hormone treatment
by Espeland, Mark A
The American journal of cardiology, 1998, Vol.82 (10), p.S37-S39
12.
Association between Alcohol Intake and Domain-Specific Cognitive Function in Older Women
by Espeland, Mark A
Neuroepidemiology, 2006-07, Vol.27 (1), p.1-12
13.
Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD)
by Espeland, M A
Clinical trials (London, England), 2006-10, Vol.3 (5), p.443-456
14.
The science of web-based clinical trial management
by Reboussin, David
Clinical trials (London, England), 2005-02, Vol.2 (1), p.1-2
15.
Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss
by Kostis, John B
The American heart journal, 2002-10, Vol.144 (4), p.625-629
16.
Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group
by Kostis, J B
The American journal of cardiology, 1998-12-15, Vol.82 (12), p.1501-1508
17.
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
by Espeland, Mark A
Current controlled trials in cardiovascular medicine, 2005-03-10, Vol.6 (1), p.3-3
18.
NONPHARMACOLOGIC MANAGEMENT HYPERTENSION IN OLDER PEOPLE
by Whelton, P K
Southern medical journal (Birmingham, Ala.), 1998-09, Vol.91 (9), p.887
19.
Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators
by Espeland, M A
The journal of clinical endocrinology and metabolism, 1997-05, Vol.82 (5), p.1549-1556
20.
Postfire Seeding and Plant Community Recovery in the Great Basin
by Kulpa, S. M
Rangeland ecology & management, 2012-03, Vol.65 (2), p.171-181
